Q3 2025 Bioceres Crop Solutions Corp Earnings Call Transcript
Key Points
- Bioceres Crop Solutions Corp (BIOX) reported a significant $40 million improvement in cash flow performance year-over-year, aiding in debt reduction and cash position enhancement.
- The company received EPA approval for Rinotec, allowing them to offer a comprehensive suite of biological solutions for pest control and plant health across major agricultural markets.
- There was a 26% increase in revenues from seed and integrated products, driven by accelerated sales of HB4 grain from existing inventory.
- The company achieved a favorable shift in product mix within crop protection, leading to a margin expansion from 38% to 41%.
- Bioceres Crop Solutions Corp (BIOX) successfully reduced its payroll by 68%, resulting in annualized savings of approximately $5 million.
- Total revenues for the quarter decreased to $60.6 million from $84 million the previous year, primarily due to the absence of a significant upfront payment from Syngenta.
- Gross profit declined from $42.6 million to $24 million, with a consolidated gross margin drop from 51% to 39%, largely due to the previous year's Syngenta payment.
- The Argentine market experienced a particularly slow third quarter, with reduced commercial activity impacting input sales.
- Adjusted EBITDA fell to $9 million from $21.1 million last year, reflecting the absence of the Syngenta payment.
- The company is still in a transitioning period, making it challenging to provide specific guidance on future EBITDA to free cash flow conversion.
Hello, everyone, and thank you for joining us on today's Bioceres Crop Solutions fiscal third quarter 2025 financial and operational results. My name is Drew and I'll be the operator on today's call. After today's prepared remarks, there will be a Q&A session. (Operator Instructions)
It's now my pleasure to hand over to Paula Savanti, Head of Investor Relations, to begin.
Thank you. Good morning, and welcome, everyone to Bioceres Crop Solutions Fiscal Third Quarter 2025 Earnings Conference Call. Our prepared remarks today will be led by our Chief Executive Officer, Federico Trucco; and our Chief Financial Officer, Enrique López Lecube; as well as our Chief Commercial Officer, Milen Marinov, all of whom will be available for the Q&A session following the presentation.
During this call, we will make forward-looking statements. These statements are based on current expectations and assumptions that are subject to various risks and uncertainties. I refer you to the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
